Three Questions

Three Questions: Bill Row, Icon

Friday, September 1, 2017

CWWeekly presents this biweekly feature as a spotlight on issues that executives in clinical research face. This week, writer Sony Salzman spoke with Bill Row, MBA, MS, divisional principal, Real World Evidence, Commercialization & Outcomes, at Icon. His focus is commercial applications of real-world evidence late phase studies for both pharmaceutical companies and CROs.

[Read More]

Three Questions: Patrick Hughes, CluePoints

Monday, August 7, 2017

CWWeekly presents this biweekly feature as a spotlight on issues that executives in clinical research face. This week writer Barbara M. Bolten spoke with Patrick Hughes, Chief Commercial Officer at CluePoints. Hughes is responsible for all sales and marketing strategy for CluePoints, and has worked in driving industry change through enabling technologies throughout his twenty year career history.

[Read More]

Three Questions: John Moore, Trialogics

Monday, July 24, 2017

CWWeekly presents this biweekly feature as a spotlight on issues that executives in clinical research face. This week, writer Suz Redfearn spoke with John Moore, formerly a venture capitalist in the technology space, now executive chairman of Trialogics, a provider of clinical trial software serving biotech and pharma partners.

[Read More]